Bimbo Begins

By Gregor Daniels

Andy, a college student, has been suffering from what torments many young men and women around the world: a lack of intelligence. But that may soon change. His university has recently partnered with a pharmaceutical company to administer drug trials for XB-112—a pill that can allegedly turn anyone into the next Einstein. He immediately volunteers.

But within a week, the pill is causing the opposite effects. He's failing his school tests, experiencing headaches, and having more erotic thoughts. Also, his body is developing curves that no man should have. As his mind changes, he begins to lose the will to turn back to normal. Worse yet, the doctor who administered XB-112 finds that Andy's body is manufacturing a contagious version of the pill in his bodily fluids.

The discovery comes a little too late. Andy's already been busy! And soon, he's going to have more like-minded friends...

• Language: English
• Publisher: Gregor Daniels
• Release date: Mar 25, 2022
• ISBN: 9781005145804

Gregor Daniels

Gregor Daniels is an erotica author that specializes in gender swap and erotic transformation fetishes. New stories are typically released weekly and feature a variety of themes. Have you ever had fantasies to be a girl? Then look no further ...Contact the author directly on Twitter to discuss stories, share your favorite ideas and fantasies, scenes, and characters, or to just talk about nothing in particular.

Book preview

Contents

One

Two

Three

Four

Five

Epilogue

Copyright © 2022 Gregor Daniels

All rights reserved.

Only ADULTS beyond this point.

All characters are adults at least eighteen years old.

1

Andy had never felt lucky in his whole life. Until he received a call back from Glynn Pharmaceuticals on the last day of October. An automated female voice imparted an address and a time in the afternoon. It conflicted with Calculus, but he eagerly skipped the class.

If this trial worked, his college attendance wouldn’t even matter.

Nor homework and tests.

He’d be as smart as the professors. Maybe even smarter.

The opportunity had arisen a month ago, when Andy had seen the notice board in his dormitory. Usually it was a place to announce part-time jobs, weather alerts, unique internships for university students, or for someone to offer overpriced tutoring. But one day, there’d been a pink leaflet halfway submerged in the mess of papers and advertisements.

It said: DRUG TRIALS SEEKING MOTIVATED VOLUNTEERS! UNIVERSITY PROGRAM PROMISES TO BOOST INTELLIGENCE WITH A SIMPLE PILL!

Just a pill? Andy had thought at the time, holding the leaflet in his hand as he recalled that Bradley Cooper movie—which had ended not so well for the protagonist.

He had thought such things were science fiction, but evidently not!

The listed phone number was a match for the phone number of the college’s health department and their division of human trials, so it was perfectly legitimate. And it wasn’t the first time the college had sought volunteers for some kind of experimental medicine. Up until the appearance of this pink leaflet—which first introduced Andy to the health department’s partnership with Glynn Pharmaceuticals—there’d been an advertisement for pills promising weight loss. He hadn’t heard about any results from those trials, but he couldn’t imagine the administration would submit students to something possibly harmful.

A magical smart pill was just what he needed, though.

He was riding the edge of flunking Calculus, and most of his other classes were no better. His parents, who had both been academically exceptional, weren’t pleased.

The motivation had simply been to improve his grades. But the waiting after calling the phone number and putting his name into the automated system had made him envision so many more possibilities, as if a simple pill could transform him into the next Einstein.

Then, a month later, he was officially in the clinical trial.

Andy drove to the address—a lot on the outskirts of the university’s future expansion zone, where the ground was barren and sporadic development had begun for new lecture and residence halls. The building was totally nondescript; it didn’t have a name over the door, writing on the windows, or a sign to distinguish it as anything other than a tiny office building. He parked and went inside, anticipating the bare minimum of a waiting room and a receptionist to greet.

There was a waiting room. However, there wasn’t a receptionist.

What the hell? Andy thought, checking the email he’d received, believing he’d overlooked a few crucial instructions about his meeting with Glynn Pharmaceuticals. Nope; it only told him to arrive at this address at this time and wait patiently.

So, he did.

He waited in a chair in an empty lobby, never hearing a sound or another car pulling up. The place reminded